Literature DB >> 33718165

m6A Modifications Play Crucial Roles in Glial Cell Development and Brain Tumorigenesis.

Jing Wang1,2, Yongqiang Sha1, Tao Sun1.   

Abstract

RNA methylation is a reversible post-transcriptional modification to RNA and has a significant impact on numerous biological processes. N 6-methyladenosine (m6A) is known as one of the most common types of eukaryotic mRNA methylation modifications, and exists in a wide variety of organisms, including viruses, yeast, plants, mice, and humans. Widespread and dynamic m6A methylation is identified in distinct developmental stages in the brain, and controls development of neural stem cells and their differentiation into neurons, glial cells such as oligodendrocytes and astrocytes. Here we summarize recent advances in our understanding of RNA methylation regulation in brain development, neurogenesis, gliogenesis, and its dysregulation in brain tumors. This review will highlight biological roles of RNA methylation in development and function of neurons and glial cells, and provide insights into brain tumor formation, and diagnostic and treatment strategies.
Copyright © 2021 Wang, Sha and Sun.

Entities:  

Keywords:  N6-methyladenosine (m6A); brain development; brain tumor; glial cell; glioma; neural stem cell

Year:  2021        PMID: 33718165      PMCID: PMC7943831          DOI: 10.3389/fonc.2021.611660

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  73 in total

Review 1.  The epitranscriptome and synaptic plasticity.

Authors:  Mathieu N Flamand; Kate D Meyer
Journal:  Curr Opin Neurobiol       Date:  2019-05-17       Impact factor: 6.627

Review 2.  Post-transcriptional gene regulation by mRNA modifications.

Authors:  Boxuan Simen Zhao; Ian A Roundtree; Chuan He
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-03       Impact factor: 94.444

3.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

4.  Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.

Authors:  Xiao-Li Ping; Bao-Fa Sun; Lu Wang; Wen Xiao; Xin Yang; Wen-Jia Wang; Samir Adhikari; Yue Shi; Ying Lv; Yu-Sheng Chen; Xu Zhao; Ang Li; Ying Yang; Ujwal Dahal; Xiao-Min Lou; Xi Liu; Jun Huang; Wei-Ping Yuan; Xiao-Fan Zhu; Tao Cheng; Yong-Liang Zhao; Xinquan Wang; Jannie M Rendtlew Danielsen; Feng Liu; Yun-Gui Yang
Journal:  Cell Res       Date:  2014-01-10       Impact factor: 25.617

5.  Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.

Authors:  Miaomiao Li; Xu Zhao; Wei Wang; Hailing Shi; Qingfei Pan; Zhike Lu; Sonia Peña Perez; Rajikala Suganthan; Chuan He; Magnar Bjørås; Arne Klungland
Journal:  Genome Biol       Date:  2018-05-31       Impact factor: 13.583

6.  m6A facilitates hippocampus-dependent learning and memory through YTHDF1.

Authors:  Hailing Shi; Xuliang Zhang; Yi-Lan Weng; Hongjun Song; Chuan He; Tao Zhou; Zongyang Lu; Yajing Liu; Zhike Lu; Jianan Li; Piliang Hao; Yu Zhang; Feng Zhang; You Wu; Jary Y Delgado; Yijing Su; Meera J Patel; Xiaohua Cao; Bin Shen; Xingxu Huang; Guo-Li Ming; Xiaoxi Zhuang
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

7.  m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas.

Authors:  Rui-Chao Chai; Fan Wu; Qi-Xue Wang; Shu Zhang; Ke-Nan Zhang; Yu-Qing Liu; Zheng Zhao; Tao Jiang; Yong-Zhi Wang; Chun-Sheng Kang
Journal:  Aging (Albany NY)       Date:  2019-02-27       Impact factor: 5.682

Review 8.  A Review in Research Progress Concerning m6A Methylation and Immunoregulation.

Authors:  Caiyan Zhang; Jinrong Fu; Yufeng Zhou
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

9.  m6A Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2.

Authors:  Junchen Chen; Yi-Chang Zhang; Chunmin Huang; Hui Shen; Baofa Sun; Xuejun Cheng; Yu-Jie Zhang; Yun-Gui Yang; Qiang Shu; Ying Yang; Xuekun Li
Journal:  Genomics Proteomics Bioinformatics       Date:  2019-05-30       Impact factor: 7.691

10.  The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.

Authors:  Deobrat Dixit; Briana C Prager; Ryan C Gimple; Hui Xian Poh; Yang Wang; Qiulian Wu; Zhixin Qiu; Reilly L Kidwell; Leo J Y Kim; Qi Xie; Kristoffer Vitting-Seerup; Shruti Bhargava; Zhen Dong; Li Jiang; Zhe Zhu; Petra Hamerlik; Samie R Jaffrey; Jing Crystal Zhao; Xiuxing Wang; Jeremy N Rich
Journal:  Cancer Discov       Date:  2020-10-06       Impact factor: 39.397

View more
  2 in total

1.  MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.

Authors:  Mingyu Du; Yi Peng; Yang Li; Wenyue Sun; Huanfeng Zhu; Jing Wu; Dan Zong; Lirong Wu; Xia He
Journal:  Cell Death Discov       Date:  2022-02-08

Review 2.  The Potential Role of m6A in the Regulation of TBI-Induced BGA Dysfunction.

Authors:  Peizan Huang; Min Liu; Jing Zhang; Xiang Zhong; Chunlong Zhong
Journal:  Antioxidants (Basel)       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.